Loading...
Immune-checkpoint inhibitors from cancer to COVID-19: A promising avenue for the treatment of patients with COVID-19 (Review)
The severe acute respiratory syndrome associated coronavirus-2 (SARS-CoV-2) poses a threat to human life worldwide. Since early March, 2020, coronavirus disease 2019 (COVID-19), characterized by an acute and often severe form of pneumonia, has been declared a pandemic. This has led to a boom in biom...
Na minha lista:
| Udgivet i: | Int J Oncol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
D.A. Spandidos
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7864014/ https://ncbi.nlm.nih.gov/pubmed/33491759 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2020.5159 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|